Jay Parrish, Chief Business Officer at Vir Biotechnology, Inc. (VIR), sold 75,000 shares at $37.95 ($2.8M) on 2020-07-01, disclosed to the SEC on 2020-07-02.
Open-market sale of $2.8M VIR by Chief Business Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| VIR | SELL | 2021-02-02 | $971K | — | Filing → |
| VIR | SELL | 2021-01-05 | $366K | — | Filing → |
| VIR | SELL | 2020-12-02 | $438K | — | Filing → |